Emergent BioSolutions Inc.
For the period ended Jun 26, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jun 26, 2026 · Filed Jun 29, 2026
EBS$6.06+3.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Indication
Indication
ACAM2000® is indicated for active immunization for the prevention of smallpox and mpox disease in individuals determined to be at high risk for smallpox or mpox infection.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.